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Available online 12 October 2021Duringwet granulation, the sample can be exposed to considerable mechanical effects, moisture content and el-
evated temperatures, and during high-shear granulation the impeller and chopper speeds can induce elevated
temperatures and influence the parameters of the products. In our work, we therefore aimed to investigate the
effect of cooling and process parameters on product parameters by factorial design in accordance with QbD
guidelines. Our other goal was to study the effect of the type of granulation, therefore two series were used to
prepare granules in a high-shear granulator, with water and binder solution as granulating fluid, at different
chopper and impeller speeds with application of factorial design. The particle size was higher when cooling in
the case of granules prepared with binder solution. The pepsin solution had a good granulating effect, the gran-
ules displayed a larger particle size, a higher breaking hardness and a favourable deformation process.







Biologically active peptides and proteins are increasingly becoming a
very important class of therapeutic agents because of their highly spe-
cific activity and very well tolerability by the human body [1,2]. This
may allow the direct application of these materials [3–5].
Pepsin, themajor digestive enzyme of gastric juice, is responsible for
themost digestive activity in the stomach [6]. It is a broad-specific endo-
peptidase that is commonly synthesized in gastric chief cells as a zymo-
gen enzyme [7]. Hydrochloric acid produced by the gastric mucosa, is
required to convert the inactive enzyme and maintain optimum acidity
(pH = 1–3) for pepsin function [8]. Typical therapeutic uses of pepsin
include pathological condition associated with hypo- or anacidity,
such as Sjögren's syndrome. As an enzyme, pepsin is also a protein. Pro-
teins are very sensitivematerials: elevated temperature, mechanical ef-
fects, moisture content [9,10], etc. can all decrease the enzymatic
activity. The stability of enzymes is one of the most important parame-
ter during formulation of dosage forms, in consequence of the great
number of factors involved [11].
Pepsin is a stable enzyme, retaining its enzyme activity (A) level in
solution for 1 year when stored at 4 °C, indicating that autohydrolysis. This is an open access article underis negligible [12], which means that it is still able to perform its enzy-
matic functions.
In the pharmaceutical industry fluid bed granulation [13], extrusion/
spheronization [14] and high-shear wet granulation are frequently uti-
lized in order to process fine cohesive powders into dense, round gran-
ules [16–19]. During high-shear granulation the dry powders are first
mixed by the impeller, which rotates through the powder bed. In the
second step, a liquid binder is added, the impeller ensuring spreading
of the liquid and the chopper breaking down wet agglomerates
[19–24]. This section can be divided into 3 further stages, wetting and
nucleation, growth and consolidation, and breakage and attrition
[25–27]. Finally, the granules are roundedwithout the addition of liquid.
On the basis of the impeller torque, Lin et al. identified 6 stages of the
granulation process: wetting stage, nucleation, growing stage, granule
shaping stage, granulation overwetting stage, binder overdosing stage
and slurry stage [28]. Some of the advantages of this technology include
increased bulk densities, improved flow properties, reduced powder
segregation and better handling properties [29–32]. The other advan-
tages of this granulation are short process time, efficient mixing of the
powder blend and lower liquid amount required than with other gran-
ulation methods [33].
Reliable technology processes demand an understanding of the
granulation processes, and identification and application of the critical
factors that determine the granulation quality [34]. The ICH Q8, Q9,
Q10 and Q12 guidelines emphasize the adoption of quality by designthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Design matrix for the factorial design.
Factors Low level (rpm) Zero level High level (rpm)
Chopper speed (x2) −1 0 +1
Impeller speed (x1) −1 0 +1
Cooling −1 – +1
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systematic approach based on scientific principles [36–38].
During wet granulation, the sample can be exposed to considerable
mechanical effects, moisture content and elevated temperatures, and
during high-shear granulation the impeller and chopper speeds can in-
duce elevated temperatures and influence the parameters of the prod-
ucts [39–42]. Several researchers have studied the effect of process
parameters on product parameters during high-shear granulation
[43–48], but the effect of temperature has not been studied. In our pre-
viouswork, we thereforemeasured the change in temperature at differ-
ent points in the chamber during granulation. We found that due to
friction, a significant temperature rise should be expected with the use
of high impeller speeds [40,42]. In the present work, we therefore
aimed to investigate the effect of critical product parameters (CPPs)
(cooling, impeller and chopper speed) on critical quality attributes
(CQAs) by factorial design in accordance with QbD guidelines. The
CQAs were the A and the particle size.
This information can deepen the understanding of the effects of dif-
ferent technological processes, which is indispensable for determina-
tion of the critical control points in the preparation of solid dosage
forms containing proteins. Preservation of the A level of pepsin and
other proteins should be taken into consideration during the formula-
tion. This study emphasizes the importance of special aspects in the pro-
cessing of solid dosage forms containing proteins. Its relevance is
constantly increasing because of the spreading of biotechnology and
protein-type active agents.
2. Materials and methods
2.1. Materials
In the course of the experimental work, purified water (distilled
water, Ph. Eur. 10th Ed.) and microcrystalline cellulose (MCC; Vivapur
101, J. Rettenmaier & Söhne GmbH + Co., Rosenberg, Germany) (D50
65 μm; bulk density 0.29 g/cm3; data fromproducer)were used. The ac-
tive pharmaceutical ingredient was porcine pepsin powder (Ph. Eur.
10th Ed., Meditop Ltd., Pilisborosjenő, Hungary) (D50 10 μm). Bovine
haemoglobin (Sigma-Aldrich), Folin-Ciocalteu reagent (Sigma-Aldrich),
trichloroacetic acid (Molar Chemicals Ltd.), hydrochloric acid (Ph. Eur.
10th Ed.) and sodium hydroxide (Ph. Eur. 10th Ed.) were used for pep-
sin activity measurement.
2.2. Sample preparation and the factorial design
Two series of granules were produced. In Series 1 (granule prepared
with binder solution), the granulatingfluidwas a 4% aqueous pepsin so-
lution (100ml), protein solutions exhibiting excellent adhesive proper-
ties [46]. The pepsin powderwas dissolved in distilledwater, andmixed
with magnetic stirrer for 30 min at room temperature. The powder
consisted of MCC (100 g).
In Series 2 (granule prepared with water), the granulating fluid was
purifiedwater (96ml), and the powdermixture contained pepsin pow-
der (4 g) and MCC (100 g). The powder was homogenized with a
Turbula mixer (Willy A. Bachofen Maschinenfabrik, Basel,
Switzerland) for 10 min.
The wet granulating process was carried out in a Pro-C-epT 4M8
high-shear granulator (ProCepTnv, Zelzate, Belgium). The diameter of
the chamber is 18.5 cm and the height is 15.2 cm.
The impeller and chopper are both positioned vertically in the high-
shear granulator, and their speedswere taken as the factors in the facto-
rial design, chosen on the basis of the preformulation studies. As the
temperaturemay increase during the process, the experimentswere re-
peatedwith cooling. In this case, a jacketed vessel was used, with water
at 20 °Cflowing between the two layers of the vessel. The granuleswere
dried at room temperature (25 ± 1 °C) for 24 h. The temperature was
continuously monitored by the high-shear granulator's software. At759high impeller speeds, the temperature increase was higher than at
low impeller speeds [15]. Therefore, cooling was also used as a factor
during factorial design.
The factorial design is a suitable method for modelling and
predicting the effects of the technological parameters (the chopper
and impeller speeds). The mixed 2-level and 3-level factorial design
was applied (Table 1). The high levels were based on the technical pa-
rameters of the high-shear granulator, and the low levels on the results
of the preformulation studies. The variation interval was the range be-
tween the high and low levels. Cooling was−1 in the case of formula-
tion without controlled temperature, and it was +1 in the case of
controlled temperature. Impeller speed levels were 300, 900, and
1500 rpm, and for the chopper speed, 500, 2750, and 5000 rpm.
The other parameters were standard (Table 2).
The experiment was based on a mixed 2-level and 3-level factorial
design, with the equation
y ¼ b0 þ b1 Lð Þx1 þ b1 Qð Þx12 þ b2 Lð Þx2 þ b2 Qð Þx22 þ b3 Lð ÞX3
þ b3 Qð ÞX32 þ b1 Lð Þ2 Lð Þx1x2 þ b1 Lð Þ2 Qð Þx1x22 þ b1 Qð Þ2 Lð Þx12x2
þ b1 Qð Þ2 Qð Þx12x22 þ b1 Lð Þ3 Lð Þx1x3 þ b1 Lð Þ3 Qð Þx1x32
þ b1 Qð Þ3 Lð Þx12x3 þ b1 Qð Þ3 Qð Þx12x32þb2 Lð Þ3 Lð Þx2x3
þ b2 Lð Þ3 Qð Þx2x32 þ b2 Qð Þ3 Lð Þx22x3 þ b2 Qð Þ3 Qð Þx22x32
where
y: the optimization parameter.
b0: the average optimization parameter value.
b1: a coefficient describing the effect of the chopper speed.
b2: a coefficient describing the effect of the impeller speed.
b3: a coefficient describing the effect of cooling.
b12: a coefficient describing the effect of the interaction of the
chopper and impeller speeds.
b13: a coefficient describing the effect of the interaction of the chop-
per speed and cooling.
b23: a coefficient describing the effect of the interaction of the impel-
ler speed and cooling.
x1: the chopper speed.




The optimization parameters were the average particle size (D50)
and the enzyme activity (A) value.2.3. Statistical evaluation
Tibco Statistica v13.4.0.14 (Statsoft, USA) software was used for the
statistical evaluation of the results. This software can calculate the coef-
ficients (b0, b1, b2, b3, b12, b13, b23) and ignore the redundant effects.
Additional coefficients were ignored manually until the adjusted R2
(Adj. R2) reached its maximum value The lack of overdetermination in
the modified equations results in a better predictive power and
promotes the determination of a robust design space [49,50].
Table 2
Standard parameters.
Standard parameters First series Second series
Amount of granulation liquid (ml) 100 96
Amount of pepsin (g) 4 4
Amount of MCC (g) 100 100
Amount of distilled water (ml) 96 96
Dosing speed of granulation liquid (ml/min) 5 5
Process time (s) 1200 1152
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The granules on the 2000 μm sieve were discarded. The samples
were evaluated with an analytical sieve series ranging from 1400 μm
to 125 μm (mesh sizes: 1400, 1250, 1120, 1000, 630, 500, 400, 315,
200 and 125 μm) (Retsch GmbH, Haan, Germany). Retsch EasySieve
2.0 software was used to calculate D50 and the distribution. The sieving
analysis timewas 10min. Our preliminary results revealed no change in
the distribution results over the 10 min. The sieve shaking was per-
formed on an analytical sieve shaker. The amplitude was 1.5 mm. The
D50 values were used for comparison.2.5. Determination of enzyme activity (A)
The A values of the samples relative to the substrate bovine
haemoglobin were measured according to the Ph. Eur. 10th Ed. The
basis of the analysis was the measurement of the amount of protein
which could not be precipitated with trichloroacetic acid. Haemoglobin
was dissolved at 2% in 0.1 M hydrochloric acid solution, and the pHwas
adjusted to 1.6 ± 0.1. The samples and the untreated pepsin powder
were dissolved at 0.25% in 0.1 M hydrochloric acid, and the pH was ad-
justed to 1.6±0.1. Incubationwas performed for 10min at 25 °C. 4% tri-
chloroacetic acid solution was used to precipitate the proteins. The
samples were filtered twice through filter paper, leached with 5 ml of
trichloroacetic acid and dried. After dilution, 1 ml of (5 M) sodium hy-
droxide and 1 ml of Folin-Ciocalteu reagent were added as colour-
producing reagent, and the solution was left to stand for 15 min at
room temperature. The relative A was determined; the A value of the
untreated pepsin was taken as 100%. The amount of non-precipitating
protein was determined at 540 nm with a UV spectrophotometer
(Unicam Heλios Alpha, Spectronic Unicam, Cambridge, UK).Fig. 1. Sample holder of breaking hardness tester.
7602.6. Mechanical property
The breaking hardness was tested for granules measuring between
630 and 1120 μm. The self-developed device contains a special speci-
men holder and a stamp, and is connected to a computer via an inter-
face; thus, not only can the ultimate deformation force be measured,
but the process (force–time and force–displacement curves) can also
be followed. If the measured plot (force–time) is parallel to the x-axis
the deformation is viscoelastic; if the plot rises linearly, the deformation
is elastic. The specimen is located horizontally and the stamp moves
vertically (Fig. 1). Twenty parallel measurements were performed. The
measuring range was 0–200 N, the speed of the stamp was 20 mm/
min, the output was 0–5 V, and the sensitivity was ±0.5% ±0.1 digit.
The sensor was UNICELL force measuring equipment, calibrated with
the C9B 20 kN cell (Hottinger Brüel & Kjaer GmbH, Darmstadt,
Germany).
2.7. Scanning electron microscopy (SEM)
A Hitachi S2400 (Hitachi Scientific Instruments Ltd., Tokyo, Japan)
scanning electron microscope was used to determine the shape and
the surface of the particles. A sputter coating apparatus, Polaron E5100
(Polaron Equipment Ltd., Hertfordshire, England), was applied to in-
duce electric conductivity on the surface of the sample. The air pressure
was 1.3–13 mPa.
2.8. Micro computed tomography (micro-CT) measurements
The micro-CT (computed tomography) measurements for further
morphological and structural characterization of the samples were car-
ried out using a Bruker Skyscan 2211 X-ray nanotomograph. The two
different types of granules were packed into quartz capillary tubes (1
and 2 mm in diameter) (Hilgenberg GmbH, Germany) and were
scanned using an open type pumped X-ray source operating at 70 kV
tube voltage and 450 μA emission current. Each sample was measured
with 3 μm pixel resolution using an 11 Mp cooled CCD camera with an
exposure time of 350 ms. A total of 1293 projection images were ob-
tained by a 180° rotation of the sample with 0.15° rotation step in
120 min scan time. After reconstruction of the images with NRecon
(Skyscan Bruker, Belgium) software, the volume rendered 3D CT images
were visualized using the CT-Vox (Skyscan Bruker, Belgium) software.Table 3
Average particle sizes (D50) and the activity (A) of the enzyme (Series 1: granules pre-
pared with binder solution; Series 2: granules prepared with water).









5000 1500 380 6.48
500 300 1394 30.79
5000 300 955 21.46
500 1500 319 9.44
2750 900 1068 19.14
1
5000 1500 962 58.23
500 300 1410 101.10
5000 300 833 80.59
500 1500 858 58.78
2750 900 1210 73.57
Series 2
−1
5000 1500 244 3.97
500 300 934 90.91
5000 300 601 40.62
500 1500 260 3.48
2750 900 660 16.42
1
5000 1500 805 46.40
500 300 863 90.95
5000 300 828 75.23
500 1500 607 42.70
2750 900 1490 68.02
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3.1. Particle size of granules
In Series 1 (granules preparedwith binder solution), the particle size
(D50) for the various samples ranged between 319 and 1410 μm
(Table 3), with an average D50 for the complete series (b0) of
972.25 μm (Eq. (1)). In Series 2 (with pepsin in the powder mixture),
D50 was less than in Series 1 (the average D50 (b0) was 768.83 μm
(Eq. (2))). The reason is that the pepsin powder started to dissolve
during the operation, and the growth of the particles then began. In
Series 1, pepsin was in the granulating liquid, and the growth of the
particles therefore began directly. In Series 2, the dissolution of pepsin
occurred during the process time, and the time of growth of the
particles was therefore less than in Series 1. The tendency was the
same both with and without cooling and in both series (Fig. 2).
The highest D50 was observed in the case of the minimum-
minimum impeller-chopper combination because the particles are sub-
ject to lower levels of breakage and friction at low impeller speed. The
other reason for this is that in this case the lower impeller speed re-
sulted in a lower temperature,which also resulted in lower evaporation.
Thus when the temperaturewas controlled (20 °C), the effect of the im-
peller speed was lower.
It can be concluded that the application of cooling has a significant
effect on the D50 value for both series. In Series 1 the b3 coefficient
was 216.5, while in Series 2 it was 454, which is almost twice as high
(Eqs. (1)–(2)). This may be due to the fact that at Series 1, pepsin is
present in the granulating liquid, which is continuously added to the
chamber in the form of a room temperature solution. The binder thus
absorbs the internal temperature of the chamber as soon as it enters
the chamber, which can be very high (48–50 °C) in the case of
granulation without cooling at high impeller speeds. In Series 2, the
coefficient b3 is much higher, (454), which can be explained by the
fact that in this case the pepsin powder, which will act as a binder, is
present in full in the chamber from the beginning of the granulation
process. Therefore, in this case, the total amount of pepsin will be the
same as the temperature of the chamber, so it can be seen that cooling
plays a more significant role in this case. Thus, it can be concluded
that using cooling, the particle size shows a clear increase (Fig. 2). This
is explained by the fact that at higher temperatures water evaporates
faster, while with cooling the rate of evaporation decreases, which
helps to maintain the proper moisture content of the particles and
thus their growth for a longer period of time.
D50 was found to be described by the following equations:Fig. 2. The response surfaces of D
761In Series 1:
y ¼ 972:25∗–212:75x1∗ þ 250:125x12∗–518:25x2∗ þ 216:5x3∗
þ 295:25x1x2∗–55:875x12x3 þ 306:75x 2x3∗ ð1Þ
R2: 0.99577; Adj. R2: 0.98096; MS Residual: 2611.62.
In Series 2:
y ¼ 768:833∗–46:5x1 þ 432:25x12∗–327:5x2∗ þ 454x3∗
þ 137:5x1x2–282x12x3 þ 188x2x3 þ 21x1x3 ð2Þ




3.2. Activity of enzyme (A)
The results showed that the effect of cooling (b3) on the A for Series
1 (56.99) was 65% higher than for Series 2 (36.61) (Fig. 3, Eqs. (3)–(4)).
The reason is that the pepsin solution is less stable than the solid form.
In Series 1, high extremities were observed in the A values. The mini-
mum A in Series 1 was 6.48% and the maximum Awas 101.1%, as com-
pared with a minimum of 3.48% and a maximum of 90.91% in Series 2.
This can be explained by the fact that in Series 2 the total quantity of
pepsin was exposed to the effect of the high impeller speed throughout
the operation time. In Series 2, however, the mechanical effects influ-
enced A throughout the process. In Series 1 pepsin was added to the
powder mixture continuously, and in this case, therefore, it was ex-
posed to mechanical effects for less time than the total process time.
This phenomenon can also be explained by the better stability of the
pepsin powder than that of the solution. Our earlier results revealed
that the pepsin solution was more sensitive to temperature than the
pepsin powder [14]. In Series 1, average A was 45.96% (b0), while in
Series 2 it was 47.85% (b0). Pepsin in powder form is more stable, and
the increase in this case is therefore lower (Eqs. (3)–(4)).
When the impeller and chopper speeds were high (1500 and
5000 rpm), A was extremely low (6.48% and 3.48%) (Table 3) without
controlled temperature, but significantly higher (58.23% and 46.40%)
at controlled temperature.
Higher speed leads to greater thermal andmechanical effects, which
result in lower A (Eqs. (3)–(4)), therefore, significantly high b2
(impeller speed) coefficient values were obtained in both cases. The
effect of the impeller speed (b2) was higher than the chopper speed50 (a) Series 1; (b) Series 2.
Fig. 3. The response surfaces of A (a) Series 1; (b) Series 2.
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mechanical effect.
A could be described with the following equations:
In Series 1:
y ¼ 45:958∗–8:3375x1∗–25:25x2∗ þ 56:99x3∗
þ 6:58x1x2–2:19x1x3–7:09x2x3 ð3Þ
R2: 0.99717; Adj. R2: 0.99152; MS Residual: 9.19.
In Series 2:
y ¼ 47:85∗–15:49x1–50:25x2∗ þ 36:61x3∗ þ 17:59x1x2
þ 9:485x1x3–11:24x12x3 þ 11:71x2x3 ð4Þ




Themechanical properties of the granules were better for Series 1
than for the compositions containing the pepsin powder in the pow-
der mixture. In the central point (900/2750) there are two or three
breaking point. The highest values were found for the samples in
the central point, independently of the technological process. The
best mechanical properties were those of the sample preparing
with pepsin solution granulation fluid (Series 1). The number of
bridges formed may be lower in the case of Series 2, because pepsin
is in the powder mixture therefore the first step is pepsin solving andFig. 4. The breaking hardness curves of central
762it can be only particular. The other reason is the bridges formed may
be stronger because bridge forming started immediately, and
accordingly hardness may be higher. The texture of this sample
was therefore the most compacted.
Not only the breaking hardness, but also the deformation process
can provide information on the processability. The breaking curve of Se-
ries 1 (Fig. 4) was very similar to those of the compacted pellets or gran-
ules (41). There were three phases: a short elastic part was followed by
a viscoelastic phase, and finally an elastic section up to the breaking
point (3.80 N ± 0.79 N). In this case, the first breaking point was
followed by an elastic section up to the second breaking point
(30.66 N ± 2.84 N). There were no meaningful irregularities in the
curves, which revealed only small deformations caused by the slightly
inhomogeneous structure. Series 2, prepared with pepsin powder mix-
ture, did not exhibit first an elastic curve, only a viscoelastic section
(Fig. 4). However, this section was not exactly parallel with the X axis.
In this case there were also two breaking points and both were lower
than for Series 1 (3.14 N ± 0.77 N and 16.26 N ± 1.75 N). In this case
50% of the samples had a third breaking point near the second breaking
point. It is well known that air exhibits elastic properties, and in this
case the amount of entrapped air was higher because of the loose struc-
ture and irregular shape (Fig. 4). The curve of Series 1 was better than
that of Series 2, but there were more irregularities than for Series 1, and
the separation of the different phases was also less marked. The struc-
ture of Series 2 was loose, containedmore coherent pores than Series 1,
which can be seen in the micro-CT results (Fig. 6). The shape of these
particles was very similar to that of Series 1 particles. These results
correlate well with our previous results, the protein (human serum
albumin) solution has very good granulating effect [46].point (2750/900) of Series 1 and Series 2.
Fig. 5. SEM images of the central points of granules (2750/900) of Series 1 (A and C) and Series 2 (B and D).
Fig. 6. The results of themicro-CTmeasurements: the volume rendered 3D CT images of the central points of granules (2750/900) of Series 1 (A) and Series 2 (B) packed in quartz capillary
tubes; the volume rendered 3D images of selected granules from each type (C and D) and the grayscale visualization of one vertical slice from images C and D (E and F).
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Fig. 5 demonstrates that the surface of the granules from Series 1
was not smooth, free particles of MCC can be seen in some places on
the surface. In this case pepsin was in the granulation liquid, therefore
it was in the solution. It can cause the formation of a pepsin film in the
deeper layers, not only on the surface, and resulted in highermechanical
stability as demonstrated in Fig. 5. The deformation process of granules
initially followed the mild viscoelastic state characteristic of the pellets.
The first cracking of the particle occurred later in time, since in this case
it can be seen in the micro-CT results (Fig. 6) that granules like pellets
were formed. The complete deformation of the granules occurred
under the effect of a larger force after a longer elastic section.
The surface of the granules from Series 2 was smoother because in
this case pepsin was in the powder mixture and partially soluble. The
particle size of pepsin was very small, approximately 10 μm. Pepsin
with a small particle size dissolved partially and undissolved, therefore
it was able to fill in surface irregularities between the particles of MCC.
Original MCC particles were rarely seen. The less bound particles on
the surface can crack faster under the influence of force (about 7–8 s),
and then the deformation continues due to the elastic property of the
pepsin film. The uneven distribution of the bonds is shown by the fact
that the deformation process takes place in two steps. This was sup-
ported by the high porosity seen inside the particle in the micro-CT
image.
3.5. Micro-CT
The internal structure of the granules can also be observed in the
micro-CT images. It can be seen that in the case of Series 1, pellet-like,
compacted granules were formed, which is also supported by the defor-
mation curves, since in this case a curve characteristic of typical pellets
with one breaking point was obtained. In this case, only few pores of
small size are observed inside the granules, which are scattered (Fig. 6).
In the second case, typical crust granules were formed, since pepsin
was in the powder mixture, but only partially dissolved during the pro-
cess. As a result, a well-observed crust was formed on the granules in
the micro-CT images, and an enrichment of pores was observed inside
the granules to the extent that they formed a coherent cavity, while
the outer layer of the granules formed a coherent crust.
4. Conclusion
It has been found that the temperature rise due to friction during
high-shear granulation has a significant effect on the properties of
pepsin-containing granules. The evaluation of the results indicated that
the effect of the impeller speed was definitely greater than that of the
chopper speed. The effect of the impeller on D50was exactly 243% in Se-
ries 1 and 704% in Series 2. It can be concluded that the application of
cooling has a statistically significant effect on the D50 value for both se-
ries (b3: 216.5 and 454). Both reduced both D50 and A. The interaction
of the factors (b23) was taken into consideration during the evaluation.
In the case of a high impeller speed, the temperature was elevated,
and the application of cooling is therefore recommended. Additional
developments are planned with a sample that demonstrates good A
(100%) with a practically useful D50 (1410 μm). This granule was
produced in Series 1, with low impeller and chopper speeds (300 and
500 rpm). As compared the two technological processes, the granules
formed with pepsin solution displayed higher breaking hardness
and favourable deformation process. With pepsin solution as
granulation liquid, the particles were larger, and from the aspect of A,
this technological process is recommended under well controlled
conditions. Based on the SEM andmicro-CT images, wewere able to de-
tect the surface of the particles and some of their structural differences.
We found that in the case of Series 2 (granules prepared with water),
the surface of the particles is more uniform and contains larger and764more cohesive pores inside than in Series 1 (granules prepared with
binder solution). During high shear granulation, as a technological pro-
cess, we have found that cooling plays an important role in the formula-
tion of a protein-type drug because the thermal effects of the operation
irreversibly denature the proteins.
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